HomepageEarnings Events Newsdesk 3 weeks ago Bristol-Myers Squibb Company (BMY) U.S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release Terex Corp (TEX) Sec Form 8K » « Eversource Energy (ES) Eversource Statement on Proposed Final Decision to Approve Aquarion Sale Newsdesk:
